Tsukasa Seya

Q: What Schools Are Affiliated With Tsukasa Seya

Tsukasa Seya is affiliated with the following schools: Hokkaido University, Nara Institute of Science and Technology, Aomori University, University of Tokyo, University of Washington, Osaka University

Tsukasa Seya's AcademicInfluence.com Rankings

Tsukasa Seya

Computer Science

#6092

World Rank

#6423

Historical Rank

Machine Learning

#1864

World Rank

#1889

Historical Rank

Artificial Intelligence

#2111

World Rank

#2147

Historical Rank

Database

#3206

World Rank

#3342

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Tsukasa Seya's Degrees

PhD Computer Science University of Tokyo
Masters Computer Science University of Tokyo
Bachelors Computer Science University of Tokyo

Similar Degrees You Can Earn

Why Is Tsukasa Seya Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Tsukasa Seya's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction (2003) (1146)
TLR3: interferon induction by double-stranded RNA including poly(I:C). (2008) (607)
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers (2016) (489)
Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells 1 (2003) (477)
Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. (2002) (469)
TIR-containing Adapter Molecule (TICAM)-2, a Bridging Adapter Recruiting to Toll-like Receptor 4 TICAM-1 That Induces Interferon-β* (2003) (454)
Maturation of Human Dendritic Cells by Cell Wall Skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: Involvement of Toll-Like Receptors (2000) (445)
Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b (1986) (396)
Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection (2003) (360)
Human Intelectin Is a Novel Soluble Lectin That Recognizes Galactofuranose in Carbohydrate Chains of Bacterial Cell Wall* (2001) (344)
Teleost TLR22 Recognizes RNA Duplex to Induce IFN and Protect Cells from Birnaviruses1 (2008) (332)
A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling (2006) (330)
Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells (2003) (325)
Riplet/RNF135, a RING Finger Protein, Ubiquitinates RIG-I to Promote Interferon-β Induction during the Early Phase of Viral Infection* (2009) (322)
Prediction of the prototype of the human Toll-like receptor gene family from the pufferfish, Fugu rubripes, genome (2003) (312)
Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3 (2009) (283)
Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. (2011) (270)
Activation of the human innate immune system by Spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis. (2002) (266)
Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein (1995) (242)
Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway1 (2008) (234)
DDX60, a DEXD/H Box Helicase, Is a Novel Antiviral Factor Promoting RIG-I-Like Receptor-Mediated Signaling (2011) (232)
THE MECHANISM OF DISCORDANT XENOGRAFT REJECTION (1988) (229)
The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. (2010) (227)
Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. (2003) (223)
Mitofusin 2 Inhibits Mitochondrial Antiviral Signaling (2009) (218)
Sensing Bacterial Flagellin by Membrane and Soluble Orthologs of Toll-like Receptor 5 in Rainbow Trout (Onchorhynchus mikiss)* (2004) (212)
Involvement of phosphatidylinositol 3-kinase in Fc gamma receptor signaling. (1994) (207)
Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells (2007) (206)
Toll‐Like Receptor 3: A Link between Toll‐Like Receptor, Interferon and Viruses (2004) (196)
Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins (1988) (195)
DEAD/H BOX 3 (DDX3) helicase binds the RIG‐I adaptor IPS‐1 to up‐regulate IFN‐β‐inducing potential (2010) (194)
Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors (2012) (192)
The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling. (2004) (191)
Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. (1998) (179)
Simultaneous Blocking of Human Toll-Like Receptors 2 and 4 Suppresses Myeloid Dendritic Cell Activation Induced by Mycobacterium bovis Bacillus Calmette-Guérin Peptidoglycan (2003) (175)
A Distinct Role of Riplet-Mediated K63-Linked Polyubiquitination of the RIG-I Repressor Domain in Human Antiviral Innate Immune Responses (2013) (173)
Functional properties of membrane cofactor protein of complement. (1989) (165)
Cutting Edge: NF-κB-Activating Kinase-Associated Protein 1 Participates in TLR3/Toll-IL-1 Homology Domain-Containing Adapter Molecule-1-Mediated IFN Regulatory Factor 3 Activation1 (2005) (154)
NAK-Associated Protein 1 Participates in Both the TLR3 and the Cytoplasmic Pathways in Type I IFN Induction1 (2006) (151)
Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. (1990) (150)
Molecular Cloning and Functional Characterization of Chicken Toll-like Receptors (2001) (150)
Antiviral responses induced by the TLR3 pathway (2011) (143)
Mycobacterium bovis BCG cell wall and lipopolysaccharide induce a novel gene, BIGM103, encoding a 7-TM protein: identification of a new protein family having Zn-transporter and Zn-metalloprotease signatures. (2002) (139)
Diversity of Sites for Measles Virus Binding and for Inactivation of Complement C3b and C4b on Membrane Cofactor Protein CD46 (*) (1995) (138)
Disruption of Mouse CD46 Causes an Accelerated Spontaneous Acrosome Reaction in Sperm (2003) (129)
Differential Type I IFN-Inducing Abilities of Wild-Type versus Vaccine Strains of Measles Virus1 (2007) (127)
Extracellular Vesicles Including Exosomes Regulate Innate Immune Responses to Hepatitis B Virus Infection (2016) (125)
Surface-Expressed TLR6 Participates in the Recognition of Diacylated Lipopeptide and Peptidoglycan in Human Cells1 (2005) (125)
DDX60 Is Involved in RIG-I-Dependent and Independent Antiviral Responses, and Its Function Is Attenuated by Virus-Induced EGFR Activation. (2015) (118)
Mycoplasma fermentans Lipoprotein M161Ag-Induced Cell Activation Is Mediated by Toll-Like Receptor 2: Role of N-Terminal Hydrophobic Portion in its Multiple Functions1 (2001) (117)
Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. (1989) (116)
EFFECTS OF TRANSFECTED COMPLEMENT REGULATORY PROTEINS, MCP, DAF, AND MCP/DAF HYBRID, ON COMPLEMENT‐MEDIATED SWINE ENDOTHELIAL CELL LYSIS (1994) (115)
Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer. (2003) (114)
Development of immunoadjuvants for immunotherapy of cancer. (2001) (113)
The Proinflammatory Cytokine Response to Chlamydia trachomatis Elementary Bodies in Human Macrophages Is Partly Mediated by a Lipoprotein, the Macrophage Infectivity Potentiator, through TLR2/TLR1/TLR6 and CD141 (2008) (112)
Adjuvant-Mediated Tumor Regression and Tumor-Specific Cytotoxic Response Are Impaired in MyD88-Deficient Mice (2004) (110)
Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. (2003) (106)
Phylogenetic and expression analysis of amphibian Xenopus Toll-like receptors (2007) (106)
Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA (2013) (105)
Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. (1993) (105)
Intelectin: a novel lipid raft-associated protein in the enterocyte brush border. (2006) (102)
Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46) (1990) (101)
Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo (2015) (101)
Dendritic Cell Maturation Induced by Muramyl Dipeptide (MDP) Derivatives: Monoacylated MDP Confers TLR2/TLR4 Activation1 (2005) (100)
Combinational recognition of bacterial lipoproteins and peptidoglycan by chicken Toll-like receptor 2 subfamily. (2008) (100)
Identification of a polyI:C-inducible membrane protein that participates in dendritic cell–mediated natural killer cell activation (2010) (99)
Human Herpesvirus 6 Variant A but Not Variant B Induces Fusion from Without in a Variety of Human Cells through a Human Herpesvirus 6 Entry Receptor, CD46 (2002) (97)
Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes (1988) (97)
Spatiotemporal Mobilization of Toll/IL-1 Receptor Domain-Containing Adaptor Molecule-1 in Response to dsRNA1 (2007) (94)
Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions. (1999) (92)
Interferon-beta induction through toll-like receptor 3 depends on double-stranded RNA structure. (2005) (92)
Mycobacterium bovis Bacillus Calmette-Guerin and Its Cell Wall Complex Induce a Novel Lysosomal Membrane Protein, SIMPLE, That Bridges the Missing Link between Lipopolysaccharide and p53-inducible Gene, LITAF(PIG7), and Estrogen-inducible Gene, EET-1 * (2001) (91)
A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy. (2017) (91)
The TLR3/TICAM-1 Pathway Is Mandatory for Innate Immune Responses to Poliovirus Infection (2011) (89)
The Clathrin-Mediated Endocytic Pathway Participates in dsRNA-Induced IFN-β Production1 (2008) (89)
IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid. (2011) (88)
Mycobacterium bovis BCG Cell Wall-Specific Differentially Expressed Genes Identified by Differential Display and cDNA Subtraction in Human Macrophages (2004) (87)
Functional Modulation of Human Macrophages Through CD46 (Measles Virus Receptor): Production of IL-12 p40 and Nitric Oxide in Association with Recruitment of Protein-Tyrosine Phosphatase SHP-1 to CD461 (2000) (85)
Phylogenetic and expression analysis of lamprey toll-like receptors. (2010) (82)
Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. (2007) (82)
Hepatitis C virus–infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells (2008) (82)
The Toll-Like Receptor 3-Mediated Antiviral Response Is Important for Protection against Poliovirus Infection in Poliovirus Receptor Transgenic Mice (2011) (81)
Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies (1992) (81)
Raftlin Is Involved in the Nucleocapture Complex to Induce Poly(I:C)-mediated TLR3 Activation* (2011) (81)
Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction. (2008) (78)
Fish soluble Toll-like receptor (TLR)5 amplifies human TLR5 response via physical binding to flagellin. (2006) (78)
Human C3b- and C4b-regulatory proteins: a new multi-gene family. (1985) (76)
Hepatitis C Virus Infection Induces Inflammatory Cytokines and Chemokines Mediated by the Cross Talk between Hepatocytes and Stellate Cells (2013) (76)
Hepatitis C Virus Core Protein Abrogates the DDX3 Function That Enhances IPS-1-Mediated IFN–Beta Induction (2010) (76)
Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway. (2010) (75)
Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice (2009) (75)
Lipoteichoic acid downregulates FcεRI expression on human mast cells through Toll-like receptor 2 (2007) (74)
Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells. (2003) (74)
PolyI:C–Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector–Mediated Tumor Elimination In Vivo (2015) (72)
A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70). (1987) (72)
Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. (2012) (71)
Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF). (1985) (71)
Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells. (2008) (70)
Prolonging discordant xenograft survival with anticomplement reagents K76COOH and FUT175. (1993) (69)
Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies (2006) (69)
Homo-oligomerization Is Essential for Toll/Interleukin-1 Receptor Domain-containing Adaptor Molecule-1-mediated NF-κB and Interferon Regulatory Factor-3 Activation* (2008) (68)
Toll‐like receptor‐mediated tyrosine phosphorylation of paxillin via MyD88‐dependent and ‐independent pathways (2003) (68)
The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer (2009) (67)
Wild-Type Measles Virus Infection in Human CD46/CD150-Transgenic Mice: CD11c-Positive Dendritic Cells Establish Systemic Viral Infection1 (2005) (67)
A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2. (2002) (67)
Expression of caveolin-1 in human T cell leukemia cell lines. (1998) (67)
TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons. (2005) (66)
The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation (2010) (65)
Functional evolution of the TICAM‐1 pathway for extrinsic RNA sensing (2009) (64)
UNC93B1 Physically Associates with Human TLR8 and Regulates TLR8-Mediated Signaling (2011) (64)
Membrane cofactor protein (CD46) in seminal plasma is a prostasome-bound form with complement regulatory activity and measles virus neutralizing activity. (1995) (63)
Soluble forms of membrane cofactor protein (CD46, MCP) are present in plasma, tears, and seminal fluid in normal subjects (1992) (63)
TLR2-Dependent Induction of IL-10 and Foxp3+CD25+CD4+ Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo (2011) (63)
Pan-Vertebrate Toll-Like Receptors During Evolution (2008) (62)
Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses. (2014) (61)
Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells. (1993) (61)
Cleaved/Associated TLR3 Represents the Primary Form of the Signaling Receptor (2013) (61)
Endosomal Localization of TLR8 Confers Distinctive Proteolytic Processing on Human Myeloid Cells (2014) (60)
STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation. (2016) (60)
Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera. (1995) (59)
Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis (2001) (59)
Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling (2013) (58)
Obstructing Shedding of the Immunostimulatory MHC Class I Chain–Related Gene B Prevents Tumor Formation (2009) (58)
Lamprey TLRs with Properties Distinct from Those of the Variable Lymphocyte Receptors1 (2007) (57)
Identification of a third component of complement-binding glycoprotein of human platelets. (1986) (57)
Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c+/CD8α+ dendritic cells (2012) (56)
Susceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CDw150: role of Toll stimulators in DC maturation and MV amplification. (2002) (54)
Fish soluble Toll-like receptor 5 (TLR5S) is an acute-phase protein with integral flagellin-recognition activity. (2005) (52)
Physical and functional interactions between STAT3 and Kaposi's sarcoma‐associated herpesvirus‐encoded LANA (2006) (52)
RIOK3-mediated phosphorylation of MDA5 interferes with its assembly and attenuates the innate immune response. (2015) (52)
Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton. (2001) (51)
Protein kinase Cδ binds TIRAP/Mal to participate in TLR signaling (2007) (51)
Extracellular RNA Sensing by Pattern Recognition Receptors (2018) (51)
Accessory Factors of Cytoplasmic Viral RNA Sensors Required for Antiviral Innate Immune Response (2016) (50)
Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy (2017) (50)
Adjuvant for vaccine immunotherapy of cancer – focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity (2015) (49)
Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes (2001) (47)
Human factor H and C4b-binding protein serve as factor I-cofactors both encompassing inactivation of C3b and C4b. (1995) (46)
Identification and characterization of membrane cofactor protein (CD46) in the human kidneys (1994) (46)
TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis (2012) (46)
Transgenic pigs expressing human decay‐accelerating factor regulated by porcine MCP gene promoter (2002) (45)
Membrane cofactor protein (MCP, CD46) in seminal plasma and on spermatozoa in normal and “sterile” subjects (1993) (45)
A Molecular Mechanism for Toll-IL-1 Receptor Domain-containing Adaptor Molecule-1-mediated IRF-3 Activation* (2010) (44)
Competition for binding sites on C3b by CR1, CR2, MCP, factor B and factor H. (1990) (44)
Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-β-inducing potential. (2011) (43)
Pathways Participating in Activation of Mouse Uterine Natural Killer Cells During Pregnancy1 (2005) (43)
Mucosal Immune Response in Nasal-Associated Lymphoid Tissue upon Intranasal Administration by Adjuvants (2018) (42)
Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). (2005) (40)
Myeloid-Derived Suppressor Cells Confer Tumor-Suppressive Functions on Natural Killer Cells via Polyinosinic:Polycytidylic Acid Treatment in Mouse Tumor Models (2013) (39)
Recognition of Viral RNA by Pattern Recognition Receptors in the Induction of Innate Immunity and Excessive Inflammation During Respiratory Viral Infections. (2017) (39)
Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2. (2007) (38)
CD46 (membrane cofactor protein of complement, measles virus receptor): structural and functional divergence among species (review). (1998) (38)
Molecular assembly of CD46 with CD9, alpha3-beta1 integrin and protein tyrosine phosphatase SHP-1 in human macrophages through differentiation by GM-CSF. (2002) (37)
C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission. (2007) (37)
Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy. (2005) (37)
TLR3-Mediated Synthesis and Release of Eotaxin-1/CCL11 from Human Bronchial Smooth Muscle Cells Stimulated with Double-Stranded RNA1 (2007) (37)
Pattern recognition receptors of innate immunity and their application to tumor immunotherapy (2010) (36)
Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP). (1991) (36)
Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46). (1992) (35)
Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling. (2015) (35)
Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46). (1994) (35)
Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells (2017) (35)
Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy (2016) (34)
Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement. (1992) (34)
Limited proteolysis of complement protein C3b by regulatory enzyme C3b inactivator: isolation and characterization of a biologically active fragment, C3d,g. (1985) (34)
Cell Type-Specific Subcellular Localization of Phospho-TBK1 in Response to Cytoplasmic Viral DNA (2013) (34)
Tumor immunotherapy using bone marrow‐derived dendritic cells overexpressing Toll‐like receptor adaptors (2007) (34)
Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein. (1994) (34)
Human cell receptor CD46 is down regulated through recognition of a membrane-proximal region of the cytoplasmic domain in persistent measles virus infection (1996) (33)
Raftlin Controls Lipopolysaccharide-Induced TLR4 Internalization and TICAM-1 Signaling in a Cell Type–Specific Manner (2016) (33)
A novel protein that participates in nonself discrimination of malignant cells by homologous complement (1997) (32)
Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46). (1995) (32)
Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: A case-control study (2009) (32)
A Novel Chicken Membrane-Associated Complement Regulatory Protein: Molecular Cloning and Functional Characterization1 (2001) (32)
Possible association of infertility with sperm-specific abnormality of CD46. (1997) (31)
A Short Consensus Repeat-Containing Complement Regulatory Protein of Lamprey That Participates in Cleavage of Lamprey Complement 31 (2004) (31)
Modulation of Double-stranded RNA Recognition by the N-terminal Histidine-rich Region of the Human Toll-like Receptor 3* (2008) (31)
Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein. (1998) (31)
Additional forms of human decay-accelerating factor (DAF). (1987) (31)
Reconstitution of C5 convertase of the alternative complement pathway with isolated C3b dimer and factors B and D. (1991) (31)
Human Regulator of Complement Activation (RCA) Gene Family Proteins and Their Relationship to Microbial Infection (1995) (30)
Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers (2008) (30)
Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo (2016) (30)
Generation of C3d,g and C3d by urokinase-treated plasma in association with fibrinolysis. (1985) (30)
The short consensus repeats 1 and 2, not the cytoplasmic domain, of human CD46 are crucial for infection of subgroup B adenovirus serotype 35. (2006) (29)
Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer (2013) (29)
Structural and Functional Properties of Complement-activating Protein M161Ag, a Mycoplasma fermentans Gene Product That Induces Cytokine Production by Human Monocytes* (1998) (29)
INAM Plays a Critical Role in IFN-γ Production by NK Cells Interacting with Polyinosinic-Polycytidylic Acid–Stimulated Accessory Cells (2014) (28)
Protein kinase Cdelta binds TIRAP/Mal to participate in TLR signaling. (2007) (28)
LRRC59 Regulates Trafficking of Nucleic Acid–Sensing TLRs from the Endoplasmic Reticulum via Association with UNC93B1 (2015) (28)
HTLV-1 Tax Induces Formation of the Active Macromolecular IKK Complex by Generating Lys63- and Met1-Linked Hybrid Polyubiquitin Chains (2017) (28)
Probing the C4-binding site on C1s with monoclonal antibodies. Evidence for a C4/C4b-binding site on the gamma-domain. (1989) (28)
Functional interfaces between TICAM-2/TRAM and TICAM-1/TRIF in TLR4 signaling. (2017) (27)
Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (MCP), and CD55 (DAF), in hematological malignancies. (1994) (26)
Double-stranded RNA promotes CTL-independent tumor cytolysis mediated by CD11b+Ly6G+ intratumor myeloid cells through the TICAM-1 signaling pathway (2017) (26)
Toll-like receptor 3 in nasal CD103+ dendritic cells is involved in immunoglobulin A production (2017) (26)
Guideline for hereditary angioedema (HAE) 2010 by the Japanese Association for Complement Research - secondary publication. (2012) (25)
The kinase complex responsible for IRF-3-mediated IFN-beta production in myeloid dendritic cells (mDC). (2006) (25)
Natural Killer Cells Recognize Friend Retrovirus-Infected Erythroid Progenitor Cells through NKG2D–RAE-1 Interactions In Vivo (2011) (25)
A toll-like receptor 3 (TLR3) agonist ARNAX for therapeutic immunotherapy. (2019) (25)
Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis. (2003) (25)
High levels of RAE-1 isoforms on mouse tumor cell lines assessed by anti-"pan" RAE-1 antibody confer tumor susceptibility to NK cells. (2002) (24)
Genomic Analysis of Idiopathic Infertile Patients with Sperm-Specific Depletion of CD46 (2001) (24)
Levels of Complement Regulatory Molecules in Lung Cancer: Disappearance of the D17 Epitope of CD55 in Small‐cell Carcinoma (1993) (23)
Ligation of human CD46 with purified complement C3b or F(ab')(2) of monoclonal antibodies enhances isoform-specific interferon gamma-dependent nitric oxide production in macrophages. (2002) (23)
Herpesvirus 6 Glycoproteins B (gB), gH, gL, and gQ Are Necessary and Sufficient for Cell-to-Cell Fusion (2013) (23)
Natural Killer Cell Activation Secondary to Innate Pattern Sensing (2011) (23)
The regulation of membrane cofactor protein (CD46) expression by the 3' untranslated region in transgenic mice. (1997) (23)
Development of Mouse Hepatocyte Lines Permissive for Hepatitis C Virus (HCV) (2011) (23)
Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2. (2011) (23)
Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis. (2002) (23)
Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines. (1996) (22)
IPS-1 Is Essential for Type III IFN Production by Hepatocytes and Dendritic Cells in Response to Hepatitis C Virus Infection (2014) (22)
High serum levels of additional IL-18 forms may be reciprocally correlated with IgE levels in patients with atopic dermatitis. (2001) (22)
The mechanism of discordant xenograft rejection. (1989) (22)
Antibodies against human Toll-like receptors (TLRs): TLR distribution and localization in human dendritic cells (2005) (22)
A covalent dimer of complement C4b serves as a subunit of a novel C5 convertase that involves no C3 derivatives. (1991) (22)
High Expression of Membrane Cofactor Protein of Complement (CD46) in Human Leukaemia Cell Lines: Implication of an Alternatively Spliced Form Containing the STA Domain in CD46 Up‐Regulation (1995) (22)
Regulatory system of guinea-pig complement C3b: tests for compatibility of guinea-pig factors H and I with human factors. (1991) (21)
The MyD88 Pathway in Plasmacytoid and CD4+ Dendritic Cells Primarily Triggers Type I IFN Production against Measles Virus in a Mouse Infection Model (2013) (21)
Identification of a polyI:C-inducible membrane protein that participates in dendritic cell–mediated natural killer cell activation (2010) (21)
Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion (2010) (21)
Regulator of Complement Activation (RCA) Locus in Chicken: Identification of Chicken RCA Gene Cluster and Functional RCA Proteins1 (2005) (21)
Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV‐responsive element in the CD46 promoter region (2002) (21)
Molecular cloning and functional characterization of guinea pig IL-12. (2001) (20)
Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy (2018) (20)
Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b. (1990) (20)
Toll‐like receptor 3 signal augments radiation‐induced tumor growth retardation in a murine model (2018) (20)
The Anti-Oxidant Ergothioneine Augments the Immunomodulatory Function of TLR Agonists by Direct Action on Macrophages (2017) (20)
Soluble CD46 (membrane cofactor protein, MCP) in human reproductive tract fluids. (1996) (20)
Dendritic Cells from Oral Cavity Induce Foxp3+ Regulatory T Cells upon Antigen Stimulation (2012) (20)
Membrane and secretory forms of mouse membrane cofactor protein (CD46) generated from a single gene through alternative splicing (1999) (19)
Alternative complement pathway‐mediated myeloid cell cytotoxicity: Repertoire of membrane factors participating in regulation of C3 deposition and cytolysis (1991) (19)
Human glomerular epithelial cells synthesize and secrete the third component of complement. (1995) (19)
Location of the interchain disulfide bonds of the fourth component of human complement (C4): evidence based on the liberation of fragments secondary to thiol-disulfide interchange reactions. (1986) (19)
DNAJB1/HSP40 Suppresses Melanoma Differentiation-Associated Gene 5-Mitochondrial Antiviral Signaling Protein Function in Conjunction with HSP70 (2017) (18)
Lipopeptides from Staphylococcus aureus as Tlr2 Ligands: Prediction with mRNA Expression, Chemical Synthesis, and Immunostimulatory Activities (2009) (18)
Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus. (1998) (17)
Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8+ T cells during vaccine immunotherapy (2016) (17)
14-3-3-zeta participates in TLR3-mediated TICAM-1 signal-platform formation. (2016) (17)
Vaccine immunotherapy with ARNAX induces tumor‐specific memory T cells and durable anti‐tumor immunity in mouse models (2018) (17)
Regulator of complement activation (RCA) gene cluster in Xenopus tropicalis (2009) (17)
Expression and characterization of membrane co-factor protein (MCP) in human skin. (1991) (17)
A MAVS/TICAM-1-Independent Interferon-Inducing Pathway Contributes to Regulation of Hepatitis B Virus Replication in the Mouse Hydrodynamic Injection Model (2014) (17)
Assessment of the Toll-like receptor 3 pathway in endosomal signaling. (2014) (17)
An Alternative Form of IL-18 in Human Blood Plasma: Complex Formation with IgM Defined by Monoclonal Antibodies1 (2001) (17)
The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium. (1997) (16)
Development of mouse models for analysis of human virus infections (2017) (16)
TAMable tumor-associated macrophages in response to innate RNA sensing (2012) (16)
Moesin Is Not a Receptor for Measles Virus Entry into Mouse Embryonic Stem Cells (1998) (16)
Structural-functional relationship of pathogen-associated molecular patterns: lessons from BCG cell wall skeleton and mycoplasma lipoprotein M161Ag. (2002) (16)
Human MD-1 homologue is a BCG-regulated gene product in monocytes: its identification by differential display. (1999) (16)
Enhancement of lymphocyte-mediated K562 cytotoxicity by antibodies against complement membrane cofactor protein (CD46) and decay-accelerating factor (CD55). (1991) (16)
Limited proteolysis of the third component of human complement, C3, by heat treatment. (1981) (15)
Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy (2020) (15)
Assay of Heparin in Plasma Using a Chromogenic Substrate and It’s Clinical Applications (1980) (15)
Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide (2018) (15)
Production of transgenic pigs expressing human DAF (CD55) regulated by the porcine MCP gene promoter. (2000) (15)
Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3 (1995) (15)
A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAF. (1993) (15)
Dendritic cell subsets involved in type I IFN induction in mouse measles virus infection models. (2014) (15)
Application of protein A-rosette assay for screening of monoclonal antibodies to human complement regulatory proteins. (1990) (15)
A comparative analysis of the antigenic, structural, and functional properties of three different preparations of recombinant human interleukin-18. (2000) (15)
Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response (2015) (15)
cGAMP Promotes Germinal Center Formation and Production of IgA in Nasal-Associated Lymphoid Tissue (2017) (14)
A monomeric human C4b-binding protein (C4bp) more efficiently inactivates C3b than natural C4bp: participation of C-terminal domains in factor I-cofactor activity. (1998) (14)
Complement Activation in Mycoplasma fermentans-Induced Mycoplasma Clearance from Infected Cells: Probing of the Organism with Monoclonal Antibodies against M161Ag (2000) (14)
Zyxin stabilizes RIG-I and MAVS interactions and promotes type I interferon response (2017) (14)
Homologous complement activation on drug-induced apoptotic cells from a human lung adenocarcinoma cell line. (1997) (14)
IL-6 and IFN-alpha from dsRNA-stimulated dendritic cells control expansion of regulatory T cells. (2010) (14)
An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma (2010) (14)
A novel simple method to purify recombinant soluble human complement receptor type 1 (sCR1) from CHO cell culture (2002) (14)
Test for Ability of Decay‐Accelerating Factor (DAF, CD55) and CD59 to Alleviate Complement‐Mediated Damage of Xeno‐Erythrocytes (1993) (13)
Recombinant interleukin‐12 and interleukin‐18 antitumor therapy in a guinea‐pig hepatoma cell implant model (2007) (13)
Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody. (1986) (13)
[Membrane cofactor protein (MCP, CD46)]. (1999) (13)
Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV) (2015) (13)
Phosphoinositide 3-Kinaseγ Controls the Intracellular Localization of CpG to Limit DNA-PKcs-Dependent IL-10 Production in Macrophages (2011) (13)
C5b‐8 Step Lysis of Swine Endothelial Cells by Human Complement and Functional Feature of Transfected CD59 (1996) (13)
Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy (2019) (13)
Human macrophages produce dimeric forms of IL-18 which can be detected with monoclonal antibodies specific for inactive IL-18. (2001) (13)
Analysis of the interaction between human TLR3 ectodomain and nucleic acids. (2006) (12)
Tumor vaccines with dsRNA adjuvant ARNAX induces antigen-specific tumor shrinkage without cytokinemia (2016) (12)
Evolution of the DEAD box helicase family in chicken: chickens have no DHX9 ortholog (2015) (12)
Effect of anticomplement reagents, K-76 COOH and FUT175, on discordant xenograft survival. (1992) (12)
Dendritic cell-derived TNF-alpha is responsible for development of IL-10-producing CD4+ T cells. (2010) (12)
Location of the inter-chain disulfide bonds of the third component of human complement. (1985) (12)
Analysis of C3b/C4b receptor (CR1) polymorphic variants by tryptic peptide mapping. (1986) (12)
Multi-Step Regulation of Interferon Induction by Hepatitis C Virus (2013) (11)
Deficiency of complement decay-accelerating factor (DAF, CD55) in non-Hodgkin's lymphoma. (1991) (11)
Nucleic Acid Sensors Involved in the Recognition of HBV in the Liver–Specific in vivo Transfection Mouse Models—Pattern Recognition Receptors and Sensors for HBV (2015) (11)
[RNA interference for mammalian cells]. (2002) (11)
The 3′‐UT of the ubiquitous mRNA of human CD46 confers selective suppression of protein production in murine cells (1999) (11)
Cellular distribution of a GPI-anchored complement regulatory protein CD59: homodimerization on the surface of HeLa and CD59-transfected CHO cells. (1998) (11)
Two receptor theory in innate immune activation: studies on the receptors for bacillus Culmet Guillen-cell wall skeleton. (2001) (11)
Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation. (1994) (10)
Infection of Different Cell Lines of Neural Origin with Subacute Sclerosing Panencephalitis (SSPE) Virus (2004) (10)
Identification and characterization of a silencer regulatory element in the 3'-flanking region of the murine CD46 gene. (2000) (10)
M161Ag is a potent cytokine inducer with complement activating function (review). (1999) (10)
The functions of the ninth component of human complement are sustained by disulfide bonds with different susceptibilities to reduction. (1994) (10)
Molecular cloning of a complementary DNA for a membrane cofactor protein (MCP, CD46)/measles virus receptor on Vero cells and its functional characterization. (1996) (10)
Isolation of RNA aptamers against human Toll-like receptor 3 ectodomain. (2006) (10)
A possible abscopal effect of post-irradiation immunotherapy in two patients with metastatic lung tumors (2014) (10)
Innate Immune Therapy For Cancer (2002) (10)
Oligomerized TICAM‐1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF‐κB activation and type I IFN induction (2009) (9)
Acute promyelocytic leukemia with CD59 deficiency. (1993) (9)
[Recognition of dsRNA by toll-like receptor 3]. (2001) (9)
Proteolytic elimination of decay-accelerating factor (DAF): lytic abnormality coincides with removal of DAF in papain-treated human erythrocytes. (1990) (9)
Tumor cell death by pattern-sensing of exogenous RNA: Tumor cell TLR3 directly induces necroptosis by poly(I:C) in vivo, independent of immune effector-mediated tumor shrinkage (2017) (9)
MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells. (2014) (9)
Homologous C3 deposition and homotypic cell adhesion in a human myeloid cell line, P39 (1993) (9)
A fluorometric method for determination of C3b inactivator. (1982) (9)
Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them. (1992) (9)
In vitro models for analysis of the hepatitis C virus life cycle (2012) (9)
C4b-binding protein and a 60,000-Dalton plasma protein share antigenic determinants with membrane cofactor protein of complement. (1990) (9)
Functional Alteration of Tumor-infiltrating Myeloid Cells in RNA Adjuvant Therapy. (2015) (9)
Toll-IL-1-receptor-containing adaptor molecule-1: a signaling adaptor linking innate immunity to adaptive immunity. (2013) (9)
Effect of the alterations in the fusion protein of measles virus isolated from brains of patients with subacute sclerosing panencephalitis on syncytium formation. (2007) (9)
Live imaging of transforming growth factor‐β activated kinase 1 activation in Lewis lung carcinoma 3LL cells implanted into syngeneic mice and treated with polyinosinic:polycytidylic acid (2016) (8)
Addendum to "Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-β-inducing potential" [Mol. Immunol. 48(4) (2011) 497-504]. (2011) (8)
Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity (2000) (8)
Vaccine adjuvant ARNAX promotes mucosal IgA production in influenza HA vaccination. (2018) (8)
Rapid purification of human complement receptor type 1 (CD35, CR1). (1996) (8)
Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. (1993) (8)
Differential-expression and tyrosine-phosphorylation profiles of caveolin isoforms in human T cell leukemia cell lines. (2005) (8)
Three soluble form messages of murine CD46 are produced through alternative mRNA splicing. (2001) (7)
Effect of mutations at the residues R25, D27, P69, and N70 of B95a-MCP on receptor activities for the measles viruses Nagahata wild-type strain and CAM vaccine strain. (1999) (7)
Human Herpesvirus 6 Variant A but Not Variant B Induces Fusion from Without in a Variety of Human Cells through a Human Herpesvirus 6 Entry Receptor , CD 46 (2002) (7)
The N-terminal domain of TIR domain-containing adaptor molecule-1, TICAM-1 (2014) (7)
Role of Syk in Fcγ receptor‐coupled tyrosine phosphorylation of Cbl in a manner susceptible to inhibition by protein kinase C (1999) (7)
Urine levels of CD46 (membrane cofactor protein) are increased in patients with glomerular diseases. (2000) (7)
Augmented Lung Adenocarcinoma Cytotoxicity by the Combination of a Genetically Modified Anti‐Lewis Y Antibody and Antibodies to Complement Regulatory Proteins (1995) (7)
Correlation between metastatic potency and the down-regulation of E-cadherin in the mouse hepatoma cell lines G-1 and G-5. (2000) (6)
Identification of a Regulatory Acidic Motif as the Determinant of Membrane Localization of TICAM-2 (2015) (6)
Involvement of phosphoinositide 3-kinase in regulation of adhesive activity of highly metastatic hepatoma cells. (1998) (6)
The J6JFH1 strain of hepatitis C virus infects human B-cells with low replication efficacy. (2014) (6)
TICAM-1 is dispensable in STING-mediated innate immune responses in myeloid immune cells. (2018) (6)
N-terminal binding site in the human toll-like receptor 3 ectodomain. (2007) (6)
The regulation of membrane cofactor protein (CD46) expression in transgenic mice: the importance of the first 125 BP of the 3' untranslated region. (1997) (6)
A wild-type Japanese measles virus strain inducing predominant early down-regulation of CD46. (1998) (5)
Significance of the N-terminal histidine-rich region for the function of the human toll-like receptor 3 ectodomain. (2008) (5)
Innate Immune Response to RNA Virus Infections (2011) (5)
Measles virus infects mouse fibroblast cell lines, but its multiplication is severely restricted in the absence of CD46 (2005) (5)
Development of an ELISA assay for soluble CD35 (C3b/C4b receptor): high levels of soluble CD35 in LE-positive patients with hematological malignancies. (1994) (5)
Protein polymorphism of human IL-18 identified by monoclonal antibodies. (2001) (5)
Innate immunity and vaccine. (2010) (5)
Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome. (2018) (5)
Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI). (2007) (5)
Regulatory system of guinea-pig complement C3b: two factor I-cofactor proteins on guinea-pig peritoneal granulocytes. (1990) (5)
Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1. (1991) (5)
The second and third amino acids of Pam2 lipopeptides are key for the proliferation of cytotoxic T cells (2018) (4)
The Role of Innate Immune Signaling in Regulation of Tumor-Associated Myeloid Cells (2015) (4)
Correction: an embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma (2014) (4)
Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathway. (1995) (4)
CD46, a complement regulatory protein/measles virus receptor, and its relation to hematological disorders. (1996) (4)
Double-stranded RNA analog and type I interferon regulate expression of Trem paired receptors in murine myeloid cells (2016) (4)
Heat-induced thiol-disulfide interchange reaction on the third component of human complement, C3. (1988) (4)
A novel cyclohexene derivative, TAK-242, selectively inhibits Toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling (2005) (4)
The fertilizing ability of human epididymal sperm (1996) (4)
Innate immune therapy for cancer. Screen for molecules capable of activating the innate immune system. (2000) (4)
Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: participation of two separate epitopes of C9 in C5b-8 binding. (1992) (3)
Participation of a MEK-independent pathway in MAP kinase activation and modulation of cell growth in mouse hepatoma cell lines. (2000) (3)
Isolation of an iC3b forming enzyme from peritoneal polymorphonuclear leukocytes of guinea pigs. (1983) (3)
[Toll-like receptors that sense viral infection]. (2004) (3)
Cytoplasmic dsRNA induces the expression of OCT3/4 and NANOG mRNAs in differentiated human cells (2019) (3)
Difference of expression levels between gene technological product delta CYT-MCP(CD46) and intact MCP(CD46) in transgenic mice. (1996) (3)
HCV and innate immunity. (2008) (3)
Dendritic Cell/NK Cell Interaction in RNA Virus Infection (2009) (3)
Measles virus takes a two-pronged attack on PP1. (2014) (3)
THE MOUSE FACTOR H ALLOTYPES WITH MULTIPLE AMINO ACID REPLACEMENT, H.l AND H.2 SHOW INDISTINGUISHABLE CO‐FACTOR ACTIVITY FOR FACTOR I (1991) (3)
Molecular remodeling of complement regulatory proteins for xenotransplantation. (1999) (3)
Inflammation and Immunity in Cancer (2015) (3)
Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement (2022) (3)
New approach to prevent complement activation on xenografts: effects of a surface-bound form of human C4b binding protein. (1998) (2)
[Chronic hepatitis C virus infection attenuates host antiviral innate immune response]. (2015) (2)
Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products. (1982) (2)
Genomic analysis of the murine membrane cofactor protein (CD46) (1998) (2)
Will there be an HCV meeting in 2020? Summary of the 17th international meeting on hepatitis C virus and related viruses. (2011) (2)
Human lymphocytes are more susceptible to measles virus than granulocytes, which is attributable to the phenotypic differences of their membrane cofactor protein (CD46). (1995) (2)
RIOK3 keeps MDA5 inactive (2015) (2)
Pattern Recognition by Dendritic Cells and Its Application to Vaccine Adjuvant for Antitumor Immunotherapy (2016) (2)
Erratum to “Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton” [Int. Immunopharmacol. 1 (2001) 1559–1569] (2002) (2)
Generation of the bioactive kallikrein-derived fragment, C3d-k, by HANE-plasma. (1985) (2)
The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in ApcMin/+ mice (2017) (2)
Granulocyte‐Dependent Extracellular Cytotoxicity is Enhanced by Complement C3bi and Independent of Phagocytosis (1991) (2)
PolyI:C and mouse survivin artificially embedding human 2B peptide induce a CD4+ T cell response to autologous survivin in HLA-A*2402 transgenic mice. (2015) (2)
UNC 93 B 1 Physically Associates with Human TLR 8 and Regulates TLR 8-Mediated Signaling (2018) (2)
Cytokine responses to eye spray adjuvants for enhancing vaccine‐induced immunity in chickens (2016) (2)
Complement Receptor Workshop (1984) (2)
[Clinical significance of membrane cofactor protein analysis]. (1990) (1)
Contribution of the serine-tiireonine-enriciied domains to the complement regulatory function of membrane cofactor protein (MCP) (1993) (1)
Receptor 3 in Human Dendritic Cells Subcellular Localization of Toll-Like (2003) (1)
The dataset of proteins specifically interacted with activated TICAM-1 (2016) (1)
Prophylactic Vaccine Targeting TLR3 on Dendritic Cells Ameliorates Eosinophilic Pneumonia in a Mouse SARS-CoV Infection Model (2022) (1)
Adjuvant Immunotherapy for Cancer: From Basic Research to Clinical Bench (2015) (1)
[Cell-associated complement regulatory proteins and their relation to disease processes]. (1991) (1)
Development of monoclonal antibodies that specifically interact with necrotic lymphoma cells (2011) (1)
[Role of Toll-like receptors in innate and adaptive immune responses]. (2009) (1)
Toll-like receptor and pattern sensing for evoking immune response. (2008) (1)
Involvement of CD46 in measles virus (MV)-mediated intracellular responses (1998) (1)
Intracellular receptors for viral and bacterial infections (PP-056) (2010) (1)
NK Activation Induced by Spirulina (2007) (1)
Reply to “Mycoplasma origin of tumor cell protein” (1998) (1)
Toll‐like Receptors (2009) (1)
ISOLATION AND CHARACTERIZATION OF RNA APTAMERS SPECIFIC FOR THE HUMAN TOLL-LIKE RECEPTOR 3 ECTODOMAIN (2009) (1)
Systemic Viral Infection CD11c-Positive Dendritic Cells Establish CD46/CD150-Transgenic Mice: Wild-Type Measles Virus Infection in Human (2005) (1)
[Role of ubiquitin ligase in innate immune response in mammal]. (2012) (1)
Evolution of the DEAD box helicase family in the chicken : chicken has no DHX 9 orthologue (2018) (1)
Functions Hydrophobic Portion in its Multiple by Toll-Like Receptor 2 : Role of N-Terminal MediatedM 161 Ag-Induced Cell Activation Is Lipoprotein Mycoplasma fermentans Toyoshima and Tsukasa Seya (2001) (1)
Instructions for use Title Dendritic Cells from Oral Cavity Induce Foxp 3 + Regulatory T Cells upon Antigen Stimulation (2019) (1)
Functional properties of the allotypes of mouse complement regulatory protein, factor H: difference of compatibility of each allotype with human factor I. (1993) (1)
In vitro and in vivo studies to prevent hyperacute rejection. (1996) (1)
[Innate immune response to RNA virus infection]. (2011) (1)
Glycan Vaccine (2019) (0)
Structure and function of soluble forms of MCP (CD46) (1993) (0)
1 TLR 3 / TICAM-1 signaling converts tumor-supporting myeloid cells to tumoricidal effectors (2017) (0)
The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in ApcMin/+ mice (2017) (0)
Macrophages (PP-047) (2010) (0)
Molecule-1 in Response to dsRNA Receptor Domain-Containing Adaptor Spatiotemporal Mobilization of Toll/IL-1 (2013) (0)
Double-Stranded RNA Smooth Muscle Cells Stimulated with from Human Bronchial Eotaxin-1 / CCL 11 TLR 3-Mediated Synthesis and Release of and Akitoshi (2006) (0)
The analysis of urinary MCP exretion in glomerulonephritis using monoclonal antibody-coated paramagnetic beads (1998) (0)
The protease-resistant N-terminal domain of TIR-domain containing adaptor molecule-1, TICAM-1 (2014) (0)
Tumor ' ( " ( B (2017) (0)
[Immunologic tests: CR3 (Mac-1, CD11b/CD18), CR4 (CD11c/CD18)]. (2005) (0)
A note of thanks to referees of Volume 34, 2007 (2007) (0)
[Immunologic tests: C3 receptor (CR1, 2)]. (2005) (0)
Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8+ T cells during vaccine immunotherapy (2016) (0)
[Membrane cofactor protein (MCP, CD46)]. (1999) (0)
Cloning and Functional Characterization Complement Regulatory Protein: Molecular A Novel Chicken Membrane-Associated (2000) (0)
Mouse complement regulatory protein Crry/p65 encompasses functions of DAF and MCP (1993) (0)
Molecular engineering of human C4bp; searching for a more potent safeguard against complement (1998) (0)
Transduction performance of various viral vectors in testicular cells and application of lentiviral vector for Sl / Sld infertile mice treatment (2012) (0)
[Structure and function of a cell-associated complement regulatory protein, membrane cofactor protein (MCP)]. (1988) (0)
Dendritic cells: function (PP-024) (2010) (0)
Advances of complement research and clinical application. Complement controlling factors and interspecies discrimination mechanisms. (1995) (0)
Instructions for use Title Adjuvant engineering for cancer immunotherapy : Development of a synthetic TLR 2 ligand withincreased cell adhesion (2017) (0)
Basic Studies on the Development of Adjuvant Immunotherapy (2007) (0)
Dendritic cell-derived TNF-α is responsible for development of IL-10-producing CD4+ T cells (2018) (0)
[Clinical significance of C3 receptors (CR1, 2, 3, 4) analysis]. (1990) (0)
Complement-mediated cell adhesion and damage: Importance of membrane-associated complement regulatory molecules for self-nonself discrimination in the complement system. (1994) (0)
Natural Killer Cells Recognize Friend Retrovirus-Infected Erythroid Progenitor Cells through NKG2D–RAE-1 Interactions In Vivo (cid:1) (2011) (0)
The 26th International Symposium of Sapporo Cancer Seminar: Innate immunity in cancer and infectious diseases (2006) (0)
Selective activation of the TLR3/TICAM-1/IRF-3 patjway for safe and effective immunotherapy in mouse models (2013) (0)
Coagulation-fibrinolytic analysis in patients with lung cancer. (1983) (0)
Multi-Step Regulation of Interferon Induction by Hepatitis C Virus (2013) (0)
RIOK 3 keeps MDA 5 inactive (2015) (0)
Title: Physical and functional interactions between STAT3 and Kaposi's Sarcoma-associated Herpesvirus-encoded LANA Running title: Physical and functional interactions between STAT3 and LANA Authors: (2017) (0)
Correction to: Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response (2019) (0)
4.01 – Toll-Like Receptors in Vertebrates (2007) (0)
The N-terminal domain of TIR domain-containing adaptor molecule-1, TICAM-1 (2014) (0)
A mechanism of activation of the complement system in acute myocandial infarction (1992) (0)
IL-6 and IFN-α from dsRNA-stimulated dendritic cells control expansion of regulatory T cells (2018) (0)
Limited localization of mouse complement regulatory protein Crry/P65 on mouse sperm (1995) (0)
Adjuvant Immunotherapy for Cancer: Evidence-Based Host Immunoactivation through Toll-Like Receptors (TLR) (2005) (0)
Instructions for use Title Toll-like receptor 3 signaling converts tumor-supportingmyeloid cells to tumoricidal effectors (2016) (0)
Letters to the Editor (1996) (0)
Innate–Acquired Linkage in Immunotherapy (2023) (0)
IL-23 / IL-17 Proinflammatory Pathway Tumor-Secreted Lactic Acid Promotes (2008) (0)
[Innate immune responses against viral infection and its suppression by viral proteins]. (2013) (0)
Immunity to virus infection (excluding retroviruses) (PP-025) (2010) (0)
Toll-like receptors, session 1 (WS-001a) Chairpersons: Kensuke Miyake, Hermann Wagner (2010) (0)
Infection Model Ameliorates Eosinophilic Pneumonia in a Mouse SARS-CoV Prophylactic Vaccine Targeting TLR3 on Dendritic Cells (2022) (0)
[CD46 deficiency]. (2000) (0)
Functional feature of C5b-8-step lysis of swine endothelial cell- transfected CD59. (1996) (0)
Zyxin stabilizes RIG-I and MAVS interactions and promotes type I interferon response (2017) (0)
Complement 3 That Participates in Cleavage of Lamprey Complement Regulatory Protein of Lamprey A Short Consensus Repeat-Containing (2004) (0)
Pathology of SARS. (2006) (0)
[Complement regulatory factors and immunologic recognition mechanism between species]. (1995) (0)
in a Mouse Infection Model Virus Type I IFN Production against Measles Dendritic Cells Primarily Triggers + CD4The MyD88 Pathway in Plasmacytoid and (2013) (0)
Assays of Heparin, ATIII and PF4 and their clinical applications (1981) (0)
Hepatitis C Virus (HCV)-Induced Inflammation: The Role of Cross-Talk Between HCV-Infected Hepatocytes and Stellate Cells (2015) (0)
Toll-like receptors, session 2 (WS-001b) Chairpersons: Osamu Takeuchi, Myung-Shik Lee (2010) (0)
TICAM-1 TIR domain structure (2014) (0)
intratumor myeloid cells through the TICAM-1 signaling pathway (2019) (0)
Involvement of the pertussis toxin-sensitive GTP-binding protein in regulation of expression and function of granulocyte complement receptor type 1 and type 3. (1994) (0)
Double-stranded RNA promotes CTL-independent tumor cytolysis mediated by CD11b+Ly6G+ intratumor myeloid cells through the TICAM-1 signaling pathway (2016) (0)
Suppression of the cytopathic effect induced by measles virus vaccine strains using monoclonal antibodies against CD46 (1996) (0)
Studies on coagulation-fibrinolytic changes and ultrastructural changes of the lung after the injection of tissue thromboplastin (1980) (0)
[Immunobiological response against RNA virus infection]. (2013) (0)
[Immunologic tests: Membrane cofactor protein (MCP, CD46)]. (2005) (0)
The essential role of a ubiquitin ligase, Riplet, in RIG-I-dependent antiviral innate immune responses (2017) (0)
Generation ofthebioactive kallikrein-deriv (1985) (0)
TICAM-1 signal maintains homeostasis of intestinal polyp formation in ApcMin/+ mice (2016) (0)
Complement-activating protein M161Ag is a Mycoplasma fermentans gene product that induces cytokine production by human monocytes (1998) (0)
Hepatitis B virus genomic nucleic acid in the activation and maturation of bone marrow-derived dendritic cells (2021) (0)
THU0094 Experimental mycoplasma fermentans infection in rheumatoid synovial fibroblasts induces m161ag expression (2001) (0)
68. Development of a Novel Non-Viral DNA Vaccine-Delivering Gene into the Nucleus of Dendritic Cells (2005) (0)
[Nucleic acid pattern recognition for innate sensing of hepatitis B virus (HBV)]. (2015) (0)
[CR1(immune adherence receptor), CR2(EB virus receptor), CR3(Mac-1, CD11b/CD18), CR4(CD11c/CD18)]. (2010) (0)
Cellular distribution of human glycosyl phosphatidyl inositol (GPI)-anchored protein CD59: Homodimerization on the cell surface (1998) (0)
ProteinsRCA Gene Cluster and Functional RCA Locus in Chicken: Identification of Chicken Regulator of Complement Activation (RCA) (2005) (0)
Acceleration of site-to-site transfer of C1- by a monoclonal antibody to C1-s. (1989) (0)
TICAM-2 TIR domain (2014) (0)
[Functions and structure of complement inactivators in membrane proteins. 3). Membrane cofactor protein]. (1988) (0)
Toll-like receptors (PP-001) (2010) (0)
X‐Irradiation Does Not Affect the Levels of Complement Regulatory Proteins, CD35 (CR1), CD55 (DAF) and CD59 on Concentrated Red Cells (1996) (0)
[Basic background for adjuvant immunotherapy]. (2012) (0)
[RNA structure recognized by Toll-like receptor 3 in innate immunity]. (2014) (0)
SY5-7Development of a non-inflammatory adjuvant for vaccine immunotherapy against cancer (2015) (0)
Primary Form of the Signaling Receptor Cleaved/Associated TLR3 Represents the (2013) (0)
[C3 receptor (CR1, 2, 3, 4)]. (1999) (0)
ignaling in a Cell Type TLR 4 Internalization and TICAM-1 S Raftlin Controls Lipopolysaccharide-Induced (2016) (0)
[Functions and structure of complement inactivators in membrane proteins. 1). C3b/C4b receptor]. (1988) (0)
Protein-Tyrosine Phosphatase SHP-1 to Nitric Oxide in Association with Recruitment Receptor ) : Production of IL-12 p 40 and Macrophages Through CD 46 ( Measles Virus Functional Modulation (2000) (0)
Erratum to: an embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma (2014) (0)
Signalling in pattern recognition (PP-057) (2010) (0)
Double-stranded RNA analog and type I interferon regulate expression of Trem paired receptors in murine myeloid cells (2016) (0)
Innate immunity, a possible counterplan against incurable immune-related diseases (2002) (0)
Cells in Response to Hepatitis C Virus Production by Hepatocytes and Dendritic IPS-1 Is Essential for Type III IFN (2014) (0)
Supplementary Material for: A MAVS/TICAM-1-Independent Interferon-Inducing Pathway Contributes to Regulation of Hepatitis B Virus Replication in the Mouse Hydrodynamic Injection Model (2017) (0)
A human CD46 mutants as a complement regulator but not a measles virus receptor: lessons for xenotransplantation (1998) (0)
NK-Activating Dendritic Cells Are Elicited by Stimulation with Toll-Like Receptor 3. [Emerging Theories of Host Defense. The 10th Meeting Hirosaki International Forum of Medical Science. Communication Center Hirosaki University School of Medicine. Hirosaki on November 21-22, 2006] (2007) (0)
Purification and Characterization of a Human Membrane Protein That Activates the Alternative Complement Pathway and Allows the Deposition of Homologous Complement C 3 By (2003) (0)
Correction to: Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response (2019) (0)
HOMOLOGY OF AN ACROSOME-REACTED SPERM-SPECIFIC ANTIGEN TO MEMBRANE COFACTOR PROTEIN (1993) (0)
[Embolic pneumopathy induced by tissue thromboplastin (author's transl)]. (1980) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Tsukasa Seya?

Tsukasa Seya is affiliated with the following schools:

Tsukasa Seya's Academic­Influence.com Rankings

Tsukasa Seya's Degrees

Similar Degrees You Can Earn

Why Is Tsukasa Seya Influential?

Tsukasa Seya's Published Works

Published Works

What Schools Are Affiliated With Tsukasa Seya?

Tsukasa Seya's AcademicInfluence.com Rankings